SCHEMBL23784395

SCHEMBL23784395

COc1cc2c(cc1OCCCN1CC3CC(C3)C1)[nH]c1ccncc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.43
▸ BRD4 O60885 1/20 0.42
▸ BRD2 P25440 1/20 0.42
▸ BRD3 Q15059 1/20 0.42
▸ EHMT2 Q96KQ7 6/20 0.41
▸ EHMT1 Q9H9B1 5/20 0.41
▸ SPIN1 Q9Y657 1/20 0.39
▸ MAPT P10636 4/20 0.38
▸ EGFR P00533 2/20 0.38
▸ PLK4 O00444 1/20 0.38
▸ GAK O14976 1/20 0.38
▸ EPHB6 O15197 1/20 0.38
▸ RIPK2 O43353 1/20 0.38
▸ ERN1 O75460 1/20 0.38
▸ STK10 O94804 1/20 0.38
▸ MAP4K4 O95819 1/20 0.38
▸ CHEK2 O96017 1/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ ERBB2 P04626 1/20 0.38
▸ LCK P06239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20581314 0.99 ACHE (0.42) ACHEBRD4BRD2BRD3EHMT2
SCHEMBL20580883 0.87 EHMT2 (0.55) EHMT2EHMT1SPIN1EGFRPLK4
SCHEMBL23784352 0.87 EHMT2 (0.53) ACHEBRD4BRD2BRD3EHMT2
Hydrochloric Acid SCHEMBL20580862 0.86 EHMT2 (0.53) ACHEBRD4BRD2BRD3EHMT2
Hydrochloric Acid SCHEMBL20581131 0.86 EHMT2 (0.54) EHMT2EHMT1SPIN1EGFRPLK4
SCHEMBL23784345 0.81 EHMT2 (0.48) ACHEBRD4BRD2BRD3EHMT2
Hydrochloric Acid SCHEMBL20581217 0.81 EHMT2 (0.47) ACHEBRD4BRD2BRD3EHMT2
SCHEMBL20581184 0.78 EHMT2 (0.55) EHMT2EHMT1SPIN1EGFRPLK4
SCHEMBL23784350 0.78 ACHE (0.49) ACHEBRD4BRD2BRD3MAPT
Hydrochloric Acid SCHEMBL28371971 0.78 ACHE (0.49) ACHEBRD4BRD2BRD3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634962-B1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-24 — — EP disclosed
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2021-12-02 — — US disclosed
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors EHMT2, EHMT1, EZH2 ACHE 1400/4885BRD4 601/4885BRD2 267/4885
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS EHMT2, EHMT1, EZH2 ACHE 1400/4885BRD4 601/4885BRD2 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback